menu
    • menu

    Company profile for Zura Bio

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zura Bio is a clinical-stage biotechnology company advancing ZB-168 in alopecia areata and other inflammatory diseases. ZB-168 is an anti IL7Rα inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura Bio aims to develop a portfolio of therapeutic indications for ZB-168, and is focused on demonstrating its efficacy, safety, dosing convenience and mechanism of action, initially in al...
    Zura Bio is a clinical-stage biotechnology company advancing ZB-168 in alopecia areata and other inflammatory diseases. ZB-168 is an anti IL7Rα inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura Bio aims to develop a portfolio of therapeutic indications for ZB-168, and is focused on demonstrating its efficacy, safety, dosing convenience and mechanism of action, initially in alopecia areata. This will build on Phase 1b data in Type 1 Diabetes demonstrating a favourable safety profile and strong biological rationale. Zura Bio is headquartered in London, UK with team members in the UK and USA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zura Biounitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    3rd Floor, 1 Ashley Road, Altrincham, Cheshire WA14 2DT, GB
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zurabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zura-bio-limited/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zura Bio Reveals 2025 Financials And Corporate Updates
    Zura Bio Reveals 2025 Financials And Corporate Updates

    19 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-19/zura-bio-reports-full-year-2025-financial-results-and-recent-corporate-updates

    PHARMIWEB
    19 Mar 2026
    Share Share
    Zura Bio Unveils TibuSURE Design for Dual IL-17A in SSC Congress
    Zura Bio Unveils TibuSURE Design for Dual IL-17A in SSC Congress

    05 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-05/zura-bio-to-present-phase-2-tibusure-study-design-poster-evaluating-dual-il-17a-and-baff-inhibition

    PHARMIWEB
    05 Mar 2026
    Share Share
    Zura Bio To Participate In Upcoming Investor Conferences
    Zura Bio To Participate In Upcoming Investor Conferences

    02 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-02/zura-bio-to-participate-in-upcoming-investor-conferences

    PHARMIWEB
    02 Mar 2026
    Share Share
    Zura Bio Closes $144M Offering as Underwriters Exercise Option
    Zura Bio Closes $144M Offering as Underwriters Exercise Option

    27 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-27/zura-bio-announces-closing-of-its-144-million-public-offering-and-full-exercise-of-the-underwriters

    PHARMIWEB
    27 Feb 2026
    Share Share
    Zura Bio Prices $125M Public Offering Of Class A Shares
    Zura Bio Prices $125M Public Offering Of Class A Shares

    25 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-25/zura-bio-announces-pricing-of-125-million-public-offering-of-class-a-ordinary-shares-and-pre-funded

    PHARMIWEB
    25 Feb 2026
    Share Share
    Zura Bio Announces Offering of Class A Shares and Pre-Funded
    Zura Bio Announces Offering of Class A Shares and Pre-Funded

    24 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260224878732/en/Zura-Bio-Announces-Proposed-Public-Offering-of-Class-A-Ordinary-Shares-and-Pre-Funded-Warrants

    BUSINESSWIRE
    24 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search